Search Within

Jedd D Wolchok

  1. "Claire Friedman"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (7)
  3. Book Section (1)
Groups
  1. Department of Medicine (15)
  2. GDMT, Medicine (15)
  3. GSK Faculty (15)
  4. Gynecologic Medicine Service (15)
  5. Gynecology Disease Management Team (15)
  6. Hematology-Oncology Fellows (15)

More Groups

People
  1. Claire Friedman (15)
  2. Alexander Shoushtari (9)
  3. Margaret Callahan (9)
  4. Michael Postow (9)
  5. Paul Chapman (9)
  6. Parisa Momtaz (7)

More People

Years
  1. 2022 (1)
  2. 2020 (1)
  3. 2018 (4)
  4. 2017 (3)
  5. 2016 (6)
Publications
  1. Journal of Clinical Oncology (5)
  2. Journal for ImmunoTherapy of Cancer (3)
  3. Advances in Immunology (1)
  4. Cancer Medicine (1)
  5. JAMA Oncology (1)
  6. JNCI: Journal of the National Cancer Institute (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (5)
  2. Biomed Central Ltd (3)
  3. Elsevier Inc. (3)
  4. American Medical Association (1)
  5. Demos Medical Publications (1)
  6. Oxford University Press (1)

More Publishers

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: Clinical outcomes and translational biomarker analyses
    Journal Article

    Friedman, C. F.; Spencer, C.; Cabanski, C. R.; Panageas, K. S.; Wells, D. K.; Ribas, A.; Tawbi, H.; Tsai, K.; Postow, M.; Shoushtari, A.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Technical considerations for normalizing digital spatial profiling data with multiple within-patient samples
    Meeting Abstract

    Hether, T.; Howes, T.; Spencer, C.; Hollman, T.; Reeves, J.; Wells, D.; Friedman, C.; LaVallee, T.; Wolchok, J.; Warren, S.
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Special considerations in immunotherapy trials
    Book Section

    Friedman, C. F.; Panageas, K. S.; Wolchok, J. D.
    In Kelly, W. K.; Halabi, S. (Eds.) Oncology Clinical Trials: Successful Design, Conduct, and Analysis. 2nd ed (2018)

    Fulltext@MSK | Save
  • HLA class I subtypes are associated with immune-related adverse events in patients with melanoma treated with ipilimumab
    Meeting Abstract

    Safonov, A.; Pluta, J.; Qian, L.; Amaravadi, R.; Applegate, A.; Buchbinder, E.; Cohen, J.; Friedman, C.; Halaban, R.; Hodi, F. S.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma
    Journal Article

    Rosner, S.; Kwong, E.; Shoushtari, A. N.; Friedman, C. F.; Betof, A. S.; Brady, M. S.; Coit, D. G.; Callahan, M. K.; Wolchok, J. D.; Chapman, P. B.; more...
    Cancer Medicine (2018)

    Fulltext@MSK | Save
  • Measuring toxic effects and time to treatment failure for nivolumab plus ipilimumab in melanoma
    Journal Article

    Shoushtari, A. N.; Friedman, C. F.; Navid-Azarbaijani, P.; Postow, M. A.; Callahan, M. K.; Momtaz, P.; Panageas, K. S.; Wolchok, J. D.; Chapman, P. B.
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Clinical benefit and toxicity of nivolumab plus ipilimumab in patients with advanced melanoma previously treated with checkpoint blockade inhibitors
    Meeting Abstract

    Friedman, C. F.; Wolchok, J. D.; Postow, M. A.; Shoushtari, A. N.; Callahan, M. K.; Momtaz, P.; Chapman, P. B.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Checkpoint inhibition and melanoma: Considerations in treating the older adult
    Journal Article

    Friedman, C. F.; Wolchok, J. D.
    Journal of Geriatric Oncology (2017)

    Fulltext@MSK | Save
  • Thinking critically about classifying adverse events: Incidence of pancreatitis in patients treated with nivolumab + ipilimumab
    Journal Article

    Friedman, C. F.; Clark, V.; Raikhel, A. V.; Barz, T.; Shoushtari, A. N.; Momtaz, P.; Callahan, M. K.; Wolchok, J. D.; Chapman, P. B.; Hellmann, M. D.; more...
    JNCI: Journal of the National Cancer Institute (2017)

    Fulltext@MSK | Save
  • Efficacy of nivolumab and ipilimumab (Nivo + Ipi) combination in melanoma patients (pts) treated at a single institution on an expanded-access program (EAP)
    Meeting Abstract

    Shoushtari, A. N.; Navid-Azarbaijani, P.; Friedman, C. F.; Panageas, K.; Postow, M. A.; Callahan, M. K.; Momtaz, P.; Campbell, S. C.; Shames, Y.; Prempeh-Keteku, N. A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save